ACUTE KIDNEY INJURY INDUCED WITH INTRAVENOUS CONTRAST AGENTS FOR MEDICAL RADIOLOGICAL INTERVENTIONS: INCIDENCE AND DETERMINATION OF THE INFLUENCING FACTORS

  • Stanislav Kukhlevskyy St. Joseph-Krankhenhaus Berlin-Tempelhof, Berlin, Germany https://orcid.org/0000-0002-4977-5929
  • Christiane Erley St. Joseph-Krankhenhaus Berlin-Tempelhof, Berlin, Germany
  • Markus Tölle Charity-University Medicine Berlin, Berlin, Germany
Keywords: Acute kidney injury, Iodinated radiographic contrast agents Non-iodinated radiographic contrast agent, Nephrology, Radiology, AKIN

Abstract

Medical radiological diagnostic or therapeutic interventions are widely used as routine medical procedures in patients of all ages. At the same time, radiographic contrast agent exposure has been increasingly blamed for acute kidney injury (AKI) which reduces patients’ quality of life. This study aimed to explore the diff erences in incidence and infl uencing factors for AKI and its subtypes among patients after radiological diagnostic or therapeutic interventions with intravenous contrast agents, including computed tomography (CT), angiography, and magnetic resonance imaging (MRI). This observational study included 8060 patients (from the large nephrological clinic in Berlin, Germany) and AKI was diagnosed according to AKIN criteria ranging. The pooled prevalence of AKI was 9 %. Patients with AKI aged 60–79 years (51%) and 80–100 years (37%), respectively, were predominant. AKI was signifi cantly associated with using iodinated radiographic contrast agents (94 %) after CT and angiography and 92 % of patients had AKIN 1. The prevalence of AKIN 2 and AKIN 3 was higher among patients after MRI with non-iodinated radiographic contrast agents. To sum up obtained results, the incidence of AKI among patients after intravenous contrast agents for medical radiological interventions is low. Diff erences in the prevalence of AKI were found to be related to age and the type of contrast agents used.

Downloads

Download data is not yet available.

References

Nijssen EC, Nelemans PJ, Rennenberg RJ, van der Molen AJ, van Ommen GV, Wildberger JE. Impact on clinical practice of updated guidelines on iodinated contrast material: CINART. European Radiology. 2020 Jul;30(7):4005-13.

https://doi.org/10.1007/s00330-020-06719-7

Chandiramani R, Cao D, Nicolas J, Mehran R. Contrast-induced acute kidney injury. Cardiovascular intervention and therapeutics. 2020 Jul;35(3):209-17.

https://doi.org/10.1007/s12928-020-00660-8

Andreucci M. Side effects of radiographic contrast media. BioMed research international. 2014 Jun 2;2014.

https://doi.org/10.1155/2014/872574

Rudnick MR, Leonberg-Yoo AK, Litt HI, Cohen RM, Hilton S, Reese PP. The controversy of contrast- induced nephropathy with intravenous contrast: what is the risk?. American Journal of Kidney Diseases. 2020 Jan 1;75(1):105-13.

https://doi.org/10.1053/j.ajkd.2019.05.022

Negishi Y, Tanaka A, Ishii H, Takagi K, Inoue Y, Uemura Y, Umemoto N, Yoshioka N, Morishima I, Asano H, Watarai M. Contrast-induced nephropathy and long-term clinical outcomes following percutaneous coronary intervention in patients with advanced renal dysfunction (estimated glomerular filtration rate< 30 ml/min/1.73 m2). The American Journal of Cardiology. 2019 Feb 1;123(3):361-7.

https://doi.org/10.1016/j.amjcard.2018.10.038

Windpessl M, Kronbichler A. Pro: Contrast-induced nephropathy-should we try to avoid contrast media in patients with chronic kidney disease?. Nephrology Dialysis Transplantation. 2018 Aug 1;33(8):1317-9.

https://doi.org/10.1093/ndt/gfy149

Erley C, Siggemann C. How Dangerous is Exposure of the Kidneys to Contrast Media? Strategies of Nephroprotection. Zentralblatt fur Chirurgie. 2019 Oct 21;144(5):482-7.

https://doi.org/10.1055/a-1011-4393

van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, Clement O, Heinz-Peer G, Stacul F, Webb JA, Thomsen HS. Post-contrast acute kidney injury-Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors. European radiology. 2018 Jul;28(7):2845-55.

https://doi.org/10.1007/s00330-017-5246-5

Ostermann M, Bellomo R, Burdmann EA, Doi K, Endre ZH, Goldstein SL, Kane-Gill SL, Liu KD, Prowle JR, Shaw AD, Srisawat N. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney international. 2020 Aug 1;98(2):294-309.

https://doi.org/10.1016/j.kint.2020.04.020

Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, Herzog CA, Joannidis M, Kribben A, Levey AS, MacLeod AM. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney international supplements. 2012 Mar;2(1):1-38.

Ostermann M, Bellomo R, Burdmann EA, Doi K, Endre ZH, Goldstein SL, Kane-Gill SL, Liu KD, Prowle JR, Shaw AD, Srisawat N. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney international. 2020 Aug 1;98(2):294-309.

https://doi.org/10.1016/j.kint.2020.04.020


Abstract views: 51
PDF Downloads: 26
Published
2022-06-27
How to Cite
1.
Kukhlevskyy S, Erley C, Tölle M. ACUTE KIDNEY INJURY INDUCED WITH INTRAVENOUS CONTRAST AGENTS FOR MEDICAL RADIOLOGICAL INTERVENTIONS: INCIDENCE AND DETERMINATION OF THE INFLUENCING FACTORS. Proc Shevchenko Sci Soc Med Sci [Internet]. 2022Jun.27 [cited 2022Oct.7];66(1). Available from: https://mspsss.org.ua/index.php/journal/article/view/663